Stephen R. Fussell, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 11,166 shares at $56.71 ($637K) on 2012-02-29, disclosed to the SEC on 2012-03-02.
Scheduled sale ($637k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.70 | 40 | $2K | 0.4% |
| 2 | $56.70 | 200 | $11K | 1.8% |
| 3 | $56.70 | 467 | $26K | 4.2% |
| 4 | $56.71 | 200 | $11K | 1.8% |
| 5 | $57.04 | 10,259 | $585K | 91.9% |
| Total | $57.01 avg | 11,166 |
| $637K |
| 100% |
| Filing → |
| ABT | SELL | 2018-03-02 | $668K | — | Filing → |
| ABT | SELL | 2018-02-21 | $3.2M | — | Filing → |
| ABT | SELL | 2018-02-21 | $3.9M | — | Filing → |